MedPath

Phase IIa study of T-5224 in RA patients

Phase 2
Conditions
Rheumatoid Arthritis
Registration Number
JPRN-jRCT2080221322
Lead Sponsor
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Male or female.
-Subject who have a diagnosis of Rheumatoid Arthritis by the ACR criteria.
-Age greater or 20 years and less than 65 years old.
-Subject who diagnosed to class 1-3 of Steinblocker dysfunction classification.

Exclusion Criteria

-Subject with autoimmune disease except RA and SS.
-Subject who is pregnancy, has possibility of pregnancy, hopes for pregnancy, is suckling.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy and safety
Secondary Outcome Measures
NameTimeMethod
Efficacy and safety
© Copyright 2025. All Rights Reserved by MedPath